✦ Now accepting manuscripts for Volume 8, 2026 — Submit your research
ISSN (Online): 2984-7310  ·  ISSN (Print): 2984-8821

About Clinova Journal

Learn about our mission, editorial team, publication ethics, and how to connect with us.

"Advancing knowledge across the frontiers of medicine, technology, and science — open and free for all."
— Clinova Editorial Committee, 2019

About the Journal

The Clinova Multi-disciplinary Research Journal (CMRJ) is an open-access, peer-reviewed publication committed to disseminating original, high-quality research that bridges the disciplines of Medical & Healthcare Sciences, Engineering & Technology, and Natural Sciences.

Clinova is owned and published by the Clinova Research Society, an international consortium of researchers, clinicians, and engineers dedicated to advancing knowledge through rigorous scholarly publishing. Since our founding in 2019, Clinova has grown to become a respected platform for multi-disciplinary research with contributors from over 40 countries.

The journal publishes original research articles, systematic reviews, meta-analyses, case reports, technical communications, editorials, and conference abstracts. Every submission undergoes our strict double-blind peer review process before acceptance.

248+Articles Published
40+Countries Represented
0.9Scopus CiteScore
18 daysAvg. Review Time
6+Years Publishing

Aims & Scope

Clinova covers three major pillars of contemporary research:

Medical & Healthcare Sciences

Cardiovascular diseases, oncology, neurology, psychiatry, paediatrics, endocrinology, infectious diseases, surgery, radiology, public health, epidemiology, pharmacology, and clinical trials.

Engineering & Technology

Artificial intelligence and machine learning, biomedical engineering, IoT and embedded systems, computer vision, robotics, data science, software engineering, cloud computing, and cybersecurity.

Natural Sciences

Biochemistry, molecular biology, genetics, environmental science, nanotechnology, materials science, chemistry, physics applications, and earth sciences.

Article Types Accepted

  • Original Research Articles — novel findings with full methodology
  • Review Articles & Meta-analyses — comprehensive literature synthesis
  • Case Reports — clinically significant or technologically novel cases
  • Technical Communications — short, focused technical findings
  • Editorials — commentary on current issues in research
  • Conference Abstracts — proceedings from affiliated conferences

Editorial Board

Our board comprises domain experts from leading institutions worldwide.

AK

Dr. Ananya Krishnamurthy

Editor-in-Chief

Professor, Department of Internal Medicine
All India Institute of Medical Sciences, New Delhi

RS

Prof. Rajiv Sharma

Associate Editor – Medical Sciences

Senior Consultant, Cardiology
NIMHANS, Bengaluru, India

PM

Dr. Priya Menon

Associate Editor – Technology

Associate Professor, Computer Science & AI
IIT Madras, Chennai, India

VN

Dr. Venkat Narayanan

Section Editor – Oncology

Head, Dept. of Surgical Oncology
Tata Memorial Hospital, Mumbai

SP

Dr. Sunita Patel

Section Editor – Pharmacology

Research Director
CSIR-CDRI, Lucknow, India

AR

Prof. Arjun Rao

Statistical Editor

Professor of Biostatistics
Sri Ramachandra Institute, Chennai

Review Process

Clinova follows a rigorous double-blind peer review system, where neither authors nor reviewers know each other's identities throughout the review process. This ensures unbiased evaluation based solely on scientific merit.

Review Stages

  • Initial Editorial Screening (1–3 days): Manuscripts are assessed for scope, formatting compliance, and ethical standards by the editorial team.
  • Plagiarism Check: All manuscripts are screened using iThenticate before external review. Manuscripts with confirmed plagiarism are rejected immediately.
  • External Peer Review (10–14 days): Each manuscript is assigned to at least two independent domain experts. Reviewers evaluate scientific rigor, originality, methodology, and clarity.
  • Editorial Decision: The Editor-in-Chief makes the final decision: Accept, Minor Revision, Major Revision, or Reject — based on reviewer recommendations.
  • Production & Publication: Accepted manuscripts are copy-edited, typeset, and published online with a DOI.

Clinova follows the Committee on Publication Ethics (COPE) guidelines at every stage of the publication process.

Abstracting & Indexing

Clinova is indexed in the following major databases:

SCOPUSCiteScore: 0.9
EMBASEExcerpta Medica
EBSCOFull-text indexed
CrossRefDOI Registration
Google ScholarFull indexing
DOAJOpen access listed

All published articles are archived in PORTICO for long-term digital preservation. Each article receives a unique Digital Object Identifier (DOI) via CrossRef.

Ethical Guidelines

The editorial team of Clinova is committed to the highest standards of integrity, transparency, and ethical practice in scholarly publishing. Our policies follow internationally recognized best practices including COPE, ICMJE, and WAME guidelines.

Plagiarism Policy

Plagiarism — whether of words, ideas, images, or data — is unacceptable. This includes self-plagiarism, where authors reuse their own previously published material without proper citation.

All manuscripts are screened using iThenticate before review. Editors and reviewers have access to these reports, and manuscripts with confirmed plagiarism are rejected outright.

Peer Review Policy

Clinova follows a double-blind peer review system to ensure fair and unbiased evaluation. Author and reviewer identities are kept confidential throughout the review. We follow the COPE Ethical Guidelines for Peer Reviewers.

Conflicts of Interest

Authors must disclose any potential conflicts — financial or otherwise — at the time of submission. These disclosures appear in the published article. We follow COPE guidance on conflicts of interest.

Errata, Retractions & Withdrawals

  • Errata: For factual errors that do not affect conclusions. A correction is published and linked to the original article.
  • Retractions: Issued when findings are invalidated due to serious errors, plagiarism, or misconduct. The original article remains with a "Retracted" watermark. We follow COPE Retraction Guidelines.
  • Withdrawals: Applied before or after acceptance when ethical or legal issues arise.
  • Expressions of Concern: Published when validity is in question but investigations are ongoing.

Patient Consent & Ethics Approval

Informed consent is required for all human participants. Manuscripts must include a statement confirming consent was obtained. Human studies require Institutional Review Board (IRB) approval with protocol number. Research involving humans must comply with the Declaration of Helsinki. Animal studies require institutional animal ethics committee approval.

Use of Artificial Intelligence (AI)

Following WAME recommendations: AI tools (e.g., ChatGPT, Claude) cannot be listed as authors. Any AI use in research, writing, or image preparation must be disclosed in the manuscript. Authors are fully responsible for accuracy, originality, and absence of plagiarism regardless of AI use.

Image Quality Standards

All images must be at least 300 DPI resolution and, when applicable, contain clear arrows or markers highlighting key findings. Clinical photographs must have eyes obscured. Radiologic images must not display patient names or identification. Low-quality images may be returned for revision before review.

In-House Submissions & Editorial Independence

Manuscripts submitted by Editors-in-Chief or editorial board members are managed by independent editors without their involvement. The journal maintains transparent governance, international editorial oversight, external peer review, and full conflict-of-interest policies, ensuring editorial decisions are based solely on scientific merit.

Informed Consent Policy

Authors must obtain written informed consent from all participants before enrollment. Consent must cover participation in the research and, where applicable, publication of identifiable information. The Methods section must include a statement confirming informed consent was obtained. Clinova reserves the right to request copies of signed consent forms at any stage before or after publication.

Adherence to COPE Core Practices

We follow COPE's core practices which include: Authorship and contributorship; Complaints and appeals; Conflicts of interest and competing interests; Data and reproducibility; Ethical oversight; Intellectual property; Journal management; Peer review processes; Post-publication discussions and corrections.

Complaints may be submitted directly to the Editor-in-Chief at editor@clinova.org. Unresolved cases may be referred to COPE.

Open Access & Licensing

Clinova is a fully open-access journal. Manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and new creations are licensed under identical terms.

Clinova does not charge article processing fees (APCs). Publication is completely free for all authors.

Archival & Preservation

All published articles are archived in PORTICO for long-term digital preservation. All articles are assigned a DOI via CrossRef. We are members of the CrossRef open metadata initiative.

Advertisement Policy

While advertisements help sustain the journal, ethical considerations ensure the integrity and content of the journal are not biased or influenced. The Editorial Board has full and final approval over all advertisement content. Advertisers will never be shown any manuscripts or other content prior to publication.

Contact Us

Reach out for submissions, editorial queries, or partnership enquiries.

Editorial Office

editor@clinova.org

Manuscript Submissions

submissions@clinova.org

Registered Office

Clinova Research Society
Bengaluru, Karnataka 560001
India

Publisher Phone

+91 80 4123 5678

Send us a message